Two Years of Sarilumab in Patients with Rheumatoid Arthritis and an Inadequate Response to MTX: Safety, Efficacy and Radiographic Outcomes
Rheumatology 2018;57:1423–1431 DOI: 10.1093/rheumatology/key121
View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.
Rheumatology 2018;57:1423–1431 DOI: 10.1093/rheumatology/key121
Lancet 2018;391:2513–24
Ann Rheum Dis 2018; 77:650–57 DOI: 10.1136/annrheumdis-2017-212395
Rheumatol Ther. 2018 Dec;5(2):341-353. doi: 10.1007/s40744-018-0113-7
Arthritis Care Res (Hoboken) 2019 Jan;71(1):71-79. DOI: 10.1002/acr.23585
Clin Rheumatol 2018 Aug; 37(8):2043–53
Arthritis Res Ther 2018; 20(1):57 doi: 10.1186/s13075-018-1541-z
Rheumatology (Oxford) 2018; 57(2):309–17
Int J Rheum Dis 2018; 21(2):402–14
Rheumatology (Oxford). 2018 Mar 1;57(3):499-507. DOI: 10.1093/rheumatology/kex443